These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30959315)

  • 1. LC-MS/MS study of the degradation processes of nitisinone and its by-products.
    Barchanska H; Rola R; Szczepankiewicz W; Mrachacz M
    J Pharm Biomed Anal; 2019 Jul; 171():15-21. PubMed ID: 30959315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of plasma and dry blood spots as samples for the determination of nitisinone (NTBC) by high-performance liquid chromatography-tandem mass spectrometry. Study of the stability of the samples at different temperatures.
    Prieto JA; Andrade F; Lage S; Aldámiz-Echevarría L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):671-6. PubMed ID: 21377430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography tandem mass spectrometry method for the quantitation of NTBC (2-(nitro-4-trifluoromethylbenzoyl)1,3-cyclohexanedione) in plasma of tyrosinemia type 1 patients.
    Herebian D; Spiekerkötter U; Lamshöft M; Thimm E; Laryea M; Mayatepek E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1453-9. PubMed ID: 19345648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of NTBC metabolites in urine from patients with hereditary tyrosinemia type 1 using two different mass spectrometric platforms: triple stage quadrupole and LTQ-Orbitrap.
    Herebian D; Lamshöft M; Mayatepek E; Spiekerkoetter U
    Rapid Commun Mass Spectrom; 2010 Mar; 24(6):791-800. PubMed ID: 20187082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiles and fingerprints for the investigation of the influence of nitisinone on the metabolism of the yeast Saccharomyces cerevisiae.
    Barchanska H; Płonka J; Nowak P; Kostina-Bednarz M
    Sci Rep; 2023 Jan; 13(1):1473. PubMed ID: 36702867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantification of succinylacetone and nitisinone for therapeutic drug monitoring in the treatment of Tyrosinemia type 1.
    Sundberg J; Wibrand F; Lund AM; Christensen M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():259-266. PubMed ID: 29195145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple and fast quantification of nitisone (NTBC) using liquid chromatography-tandem mass spectrometry method in plasma of tyrosinemia type 1 patients.
    Davit-Spraul A; Romdhane H; Poggi-Bach J
    J Chromatogr Sci; 2012 May; 50(5):446-9. PubMed ID: 22511487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of nitisinone and its metabolites on l-tyrosine metabolism in a model system.
    Płonka J; Babiuch M; Barchanska H
    Chemosphere; 2022 Jan; 286(Pt 1):131592. PubMed ID: 34311397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of (4-hydroxyphenyl)pyruvate dioxygenase with the specific inhibitor 2-[2-nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedione.
    Kavana M; Moran GR
    Biochemistry; 2003 Sep; 42(34):10238-45. PubMed ID: 12939152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosinemia I, a model for human diseases mediated by 2-oxoacid-utilizing dioxygenases: hepatotoxin suppression by NTBC does not normalize hepatic collagen metabolism.
    Hanauske-Abel HM; Popowicz A; Remotti H; Newfield RS; Levy J
    J Pediatr Gastroenterol Nutr; 2002 Jul; 35(1):73-8. PubMed ID: 12142814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of NTBC in serum samples from patients with hereditary tyrosinemia type I by capillary electrophoresis.
    Cansever MS; Aktuğlu-Zeybek AC; Erim FB
    Talanta; 2010 Mar; 80(5):1846-8. PubMed ID: 20152421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 2-[2-nitro-4-(trifluoromethyl)benzoyl]- cyclohexane-1,3-dione metabolites in urine of patients suffering from tyrosinemia type I with the use of 1H and 19F NMR spectroscopy.
    Szczeciński P; Lamparska D; Gryff-Keller A; Gradowska W
    Acta Biochim Pol; 2008; 55(4):749-52. PubMed ID: 19039335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS method for simultaneous determination on a dried blood spot of multiple analytes relevant for treatment monitoring in patients with tyrosinemia type I.
    la Marca G; Malvagia S; Materazzi S; Della Bona ML; Boenzi S; Martinelli D; Dionisi-Vici C
    Anal Chem; 2012 Jan; 84(2):1184-8. PubMed ID: 22148291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary Tyrosinemia Type 1 in Turkey.
    Aktuglu-Zeybek AC; Kiykim E; Cansever MS
    Adv Exp Med Biol; 2017; 959():157-172. PubMed ID: 28755194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring tyrosinaemia type I: Blood spot test for nitisinone (NTBC).
    Sander J; Janzen N; Terhardt M; Sander S; Gökcay G; Demirkol M; Ozer I; Peter M; Das AM
    Clin Chim Acta; 2011 Jan; 412(1-2):134-8. PubMed ID: 20883679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of the triketone herbicide mesotrione by a Bacillus strain. Metabolite profiling using liquid chromatography/electrospray ionization quadrupole time-of-flight mass spectrometry.
    Durand S; Légeret B; Martin AS; Sancelme M; Delort AM; Besse-Hoggan P; Combourieu B
    Rapid Commun Mass Spectrom; 2006; 20(17):2603-13. PubMed ID: 16878338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory monitoring of patients with hereditary tyrosinemia type I.
    Schultz MJ; Netzel BC; Singh RH; Pino GB; Gavrilov DK; Oglesbee D; Raymond KM; Rinaldo P; Tortorelli S; Smith WE; Matern D
    Mol Genet Metab; 2020 Aug; 130(4):247-254. PubMed ID: 32546364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the ferrous form of (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis in complex with the therapeutic herbicide, NTBC.
    Brownlee JM; Johnson-Winters K; Harrison DH; Moran GR
    Biochemistry; 2004 Jun; 43(21):6370-7. PubMed ID: 15157070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive changes in liver gene expression induced by hereditary tyrosinemia type I are not normalized by treatment with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC).
    Luijerink MC; Jacobs SM; van Beurden EA; Koornneef LP; Klomp LW; Berger R; van den Berg IE
    J Hepatol; 2003 Dec; 39(6):901-9. PubMed ID: 14642604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Weed Killer to Wonder Drug.
    Lock EA
    Adv Exp Med Biol; 2017; 959():175-185. PubMed ID: 28755195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.